Establishment Labs Q3 revenue up 34%, beats estimates
ESTA•Establishment Labs reported third-quarter revenue of $71.99 million, up 34% year over year and above the $66.46 million consensus, while its $0.35 per-share loss exceeded estimates. The company raised 2026 revenue guidance to more than $274 million and said it achieved its first positive operating and free cash flow in Q3.
1. Revenue and losses
Third-quarter revenue rose 34% year over year to $71.99 million, beating analyst expectations of $66.46 million. Establishment Labs reported a net loss of $10.71 million, or $0.35 per share, compared with consensus estimates for a $7.95 million net loss and a $0.26 per-share loss.
2. Growth and outlook
The company said U.S. sales increased 119% and revenue from its minimally invasive platform rose 124%, driving Q3 growth. It achieved its first positive operating and free cash flow in the quarter. Establishment Labs raised its 2026 revenue guidance to more than $274 million from $269 million to $271 million, expects an adjusted gross margin of about 70.7%, and maintained its adjusted operating expense forecast of $195 million to $200 million.
